Study-Update: Long non-coding RNA MEG3 suppresses survival, migration, and invasion of cervical cancer
The expression of MEG3 was downregulated in cervical intraepithelial neoplasia and squamous cell carcinoma tissues.
Reasons why the screening programs may not be uniform
We may tend to think of our health-care system as a national program. In reality, the states and territories are responsible for delivering health-care services. That means local authorities are in charge of setting up health programs and sometimes opinions vary about what’s the best approach. As a result, cancer screening can differ from one…
A guide to cervical cancer screenings at every age
What to know before you go to your annual gynecology appointment
The American College of Obstetricians and Gynecologists still recommend that women over 30 undergo “co-testing,” or both the Pap smear and the HPV test.
“The good news is A, the HPV vaccine is likely to make a big impact on women, and B, the screening frequency is probably going to go down in the near future,”
Less than a third of women could confidently recognise cervical cancer symptoms
Nobody ever really believes they could get a life-threatening illness when they’re young – we all somehow believe we’re invincible in our twenties and thirties, and even beyond. But in reality, that’s not the case. And while we don’t want to spend our lives worrying about something that might never happen, it can certainly pay…
Treatment choices in Cervical cancer
Image source Cleveland Clinical health
A New HPV Test Shows Promising Results In Detecting The Development Of Cervical Cancer
Cervical cancer is often detected through Pap smears; after all, there is a correlation between human papillomavirus (HPV) infections and cervical cancer. But now, a study shows that a new HPV test showed promising results in finding precancerous cervical changes. And, not only that, but the test was more accurate than Pap smears at doing…
Study Suggests HPV Test More Accurate Than Pap Smear for Cervical Cancer Screening
When it comes to cervical cancer screening, most women receive a cytology-based Papanicolau (Pap) smear, where cells are scraped from the back of the cervix. However, human papillomavirus (HPV)-based testing may be a more accurate way of testing for cervical cancer, new study results suggest.1 Despite the widespread use of cervical cancer screening with a…
Latest Nature Study – Cervical Cancer Revelations
Histologically, CC can be characterized by two different sub-categories i.e. (i) invasive squamous cell carcinomas (ISCC) which are frequent and covers 85–90% of CC cases (ii) adenocarcinomas (ADC) which are relatively rare and comprises only 10–15% cases. The CC develops progression of precancerous lesions; called cervical intraepithelial neoplasia (CIN) grade 1–3 or squamous intraepithelial lesion (SIL).
Cervical Cancer Call to Eradicate
This is the third national call to action from NCI-designated cancer centers, with the first statement published in 2016. All 70 cancer centers, representing the nation’s leaders in cancer care and research, perceive low vaccination rates as a public health threat and call upon physicians, parents and young adults to take advantage of this opportunity…